Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants

被引:3
|
作者
Usher, Inga [1 ]
Ligammari, Lorena [1 ]
Ahrabi, Sara [2 ]
Hepburn, Emily [3 ]
Connolly, Calum [3 ]
Bond, Gareth L. [4 ]
Flanagan, Adrienne M. [1 ,5 ]
Cottone, Lucia [1 ]
机构
[1] UCL, UCL Canc Inst, Dept Pathol Res, London, England
[2] UCL, UCL Canc Inst, Dept Haematol, London, England
[3] UCL, UCL Med Sch, London, England
[4] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, England
[5] Royal Natl Orthopaed Hosp, Dept Histopathol, London, England
来源
关键词
CRISPR; Cas9; genome editing; prime editing; homology directed repair (HDR); cell line; stem cells; CELLS; PRECISE; NUCLEASE;
D O I
10.3389/fgeed.2022.932434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CRISPR/Cas9, base editors and prime editors comprise the contemporary genome editing toolbox. Many studies have optimized the use of CRISPR/Cas9, as the original CRISPR genome editing system, in substituting single nucleotides by homology directed repair (HDR), although this remains challenging. Studies describing modifications that improve editing efficiency fall short of isolating clonal cell lines or have not been validated for challenging loci or cell models. We present data from 95 transfections using a colony forming and an immortalized cell line comparing the effect on editing efficiency of donor template modifications, concentration of components, HDR enhancing agents and cold shock. We found that in silico predictions of guide RNA efficiency correlated poorly withactivity in cells. Using NGS and ddPCR we detected editing efficiencies of 5-12% in the transfected populations which fell to 1% on clonal cell line isolation. Our data demonstrate the variability of CRISPR efficiency by cell model, target locus and other factors. Successful genome editing requires a comparison of systems and modifications to develop the optimal protocol for the cell model and locus. We describe the steps in this process in a flowchart for those embarking on genome editing using any system and incorporate validated HDR-boosting modifications for those using CRISPR/Cas9.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] CRISPR/Cas9 Editing for Gaucher Disease Modelling
    Pavan, Eleonora
    Ormazabal, Maximiliano
    Peruzzo, Paolo
    Vaena, Emilio
    Rozenfeld, Paula
    Dardis, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [22] CRISPR/Cas9 editing of carotenoid genes in tomato
    Caterina D’Ambrosio
    Adriana Lucia Stigliani
    Giovanni Giorio
    Transgenic Research, 2018, 27 : 367 - 378
  • [23] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525
  • [24] CRISPR/Cas9 editing for the treatment of human diseases
    Libertini, Silvana
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2023, 64 : 28 - 28
  • [25] CRISPR/CAS9: THE GOLD STANDARD OF GENOME EDITING?
    Gleeson, Alfie
    Sawyer, Abigail
    BIOTECHNIQUES, 2018, 64 (06) : 239 - 244
  • [26] CRISPR/Cas9 and other techniques for genome editing
    Hartung, Frank
    Schiemann, Jochen
    Sprink, Thorben
    ZWEITES SYMPOSIUM ZIERPFLANZENZUCHTUNG, 2017, 2017, 457 : 36 - 39
  • [27] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [28] CRISPR/Cas9 Essential Gene Editing in Drosophila
    Osadchiy, I. S.
    Kamalyan, S. O.
    Tumashova, K. Y.
    Georgiev, P. G.
    Maksimenko, O. G.
    ACTA NATURAE, 2023, 15 (02): : 70 - 74
  • [29] Optical Control of CRISPR/Cas9 Gene Editing
    Hemphill, James
    Borchardt, Erin K.
    Brown, Kalyn
    Asokan, Aravind
    Deiters, Alexander
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (17) : 5642 - 5645
  • [30] Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo
    Jiabin Zhang
    Jung-Hwan Lee
    Ju Jiao
    Du Cheng
    Li Liu
    Hae-Won Kim
    Yu Tao
    Mingqiang Li
    Signal Transduction and Targeted Therapy, 6